SEC 13F Intelligence

Managers / Q3 2025 · view latest →

Privium Fund Management B.V.

CIK 0001795097 · GUSTAV MAHLERPLEIN 3, AMSTERDAM, P7, 1082 MS · 31 20 462 6644

Reported Value
$556M
Q3 2025
Positions
59
Filings on Record
20
2019–present window
Filed
Nov 4, 2025
original filing

Summary

Privium Fund Management B.V. reported $556M in U.S.-listed holdings across 59 positions for Q3 2025.

Its largest position, TSLA, represents 19.5% of the portfolio.

Compared with Q2 2025, the fund opened 8 new positions and exited 4.

Portfolio Metrics

Turnover
+8.0%
vs prior filed quarter
Top-10 Concentration
+74.8%
share of reported value
Largest Position
+19.5%
Tesla
New / Exited
8 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $504MQ4 ’21Q1 ’22: $452MQ2 ’22: $302MQ3 ’22: $275MQ3 ’22Q4 ’22: $264MQ1 ’23: $298MQ2 ’23: $347MQ2 ’23Q3 ’23: $336MQ4 ’23: $359MQ1 ’24: $374MQ1 ’24Q2 ’24: $392MQ3 ’24: $402MQ4 ’24: $442MQ4 ’24Q1 ’25: $384MQ2 ’25: $464MQ3 ’25: $556MQ3 ’25Q4 ’25: $543MQ1 ’26: $480Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.5%ADR: 7.3%Other: 2.2%ETP: 0.1%
  • Common Stock · 90.5% · $503M
  • ADR · 7.3% · $40M
  • Other · 2.2% · $12M
  • ETP · 0.1% · $691,803

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AMDADVANCED MICRO DEVICES INCNEW+60.0K60.0K+$10M$10M
LMNDLEMONADE INCNEW+145.0K145.0K+$8M$8M
IRENIREN LIMITEDNEW+130.0K130.0K+$6M$6M
ASTSAST SPACEMOBILE INCNEW+110.0K110.0K+$5M$5M
ABVXABIVAX SANEW+30.4K30.4K+$3M$3M
BEAMBEAM THERAPEUTICS INCNEW+61.0K61.0K+$1M$1M
SLBSCHLUMBERGER LTDNEW+19.7K19.7K+$676,986$676,986
RIGTRANSOCEAN LTDNEW+102.0K102.0K+$318,240$318,240

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

59 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TSLATESLA INChistory →COM19.51%$109M244.0K
2SPOTSPOTIFY TECHNOLOGY S Ahistory →SHS11.92%$66M95.0K
3SHOPSHOPIFY INChistory →CL A SUB VTG SHS11.09%$62M415.0K
4PLTRPALANTIR TECHNOLOGIES INChistory →CL A6.56%$36M200.0K
5AMZNAMAZON COM INChistory →COM5.88%$33M149.0K
6SESEA LTDhistory →SPONSORD ADS5.14%$29M160.0K
7COINCOINBASE GLOBAL INChistory →COM CL A4.79%$27M79.0K
8QUREUNIQURE NVhistory →SHS4.05%$23M386.0K
9ARWRARROWHEAD PHARMACEUTICALS INhistory →COM2.94%$16M474.0K
10IONSIONIS PHARMACEUTICALS INChistory →COM2.93%$16M248.9K
11NVDANVIDIA CORPORATIONhistory →COM2.72%$15M81.0K
12PROQR THRAPEUTICS N VSHS EURO1.91%$11M5.00M
13AMDADVANCED MICRO DEVICES INChistory →COM1.75%$10M60.0K
14RAREULTRAGENYX PHARMACEUTICAL INhistory →COM1.57%$9M289.8K
15LMNDLEMONADE INChistory →COM1.40%$8M145.0K
16BIIBBIOGEN INChistory →COM1.31%$7M51.9K
17AXSMAXSOME THERAPEUTICS INChistory →COM1.15%$6M52.7K
18IRENIREN LIMITEDhistory →ORDINARY SHARES1.10%$6M130.0K
19ARQTARCUTIS BIOTHERAPEUTICS INChistory →COM1.04%$6M306.0K
20MRKMERCK & CO INCCOM0.97%$5M64.4K
21ASTSAST SPACEMOBILE INCCOM CL A0.97%$5M110.0K
22ZLABZAI LAB LTDADR0.81%$4M132.2K
23URGNUROGEN PHARMA LTDCOM0.71%$4M196.6K
24VRTXVERTEX PHARMACEUTICALS INCCOM0.58%$3M8.3K
25CRSPCRISPR THERAPEUTICS AGNAMEN AKT0.47%$3M40.0K
26ABVXABIVAX SASPONSORED ADS0.46%$3M30.4K
27AVIDITY BIOSCIENCES INCCOM0.42%$2M53.0K
28HIMSHIMS & HERS HEALTH INCCOM CL A0.41%$2M40.0K
29KRYSKRYSTAL BIOTECH INCCOM0.39%$2M12.2K
30ABEVAMBEV SASPONSORED ADR0.36%$2M897.1K
31ROIVROIVANT SCIENCES LTDSHS0.35%$2M126.9K
32BNTXBIONTECH SESPONSORED ADS0.34%$2M19.0K
33FDMT4D MOLECULAR THERAPEUTICS INCOM0.31%$2M197.5K
34ACADACADIA PHARMACEUTICALS INCCOM0.27%$2M70.4K
35BEAMBEAM THERAPEUTICS INCCOM0.27%$1M61.0K
36RCKTROCKET PHARMACEUTICALS INCCOM0.25%$1M432.8K
37MEIRAGTX HLDGS PLCCOM0.24%$1M163.0K
38LXEOLEXEO THERAPEUTICS INCCOM0.23%$1M192.4K
39WVEWAVE LIFE SCIENCES LTDSHS0.22%$1M170.0K
40MRNAMODERNA INCCOM0.22%$1M47.0K
41SASEABRIDGE GOLD INCCOM0.21%$1M48.5K
42PFEPFIZER INCCOM0.17%$961,87037.8K
43ALXOALX ONCOLOGY HLDGS INCCOM0.17%$931,578509.1K
44VZLAVIZSLA SILVER CORPCOM NEW0.16%$884,105204.7K
45NOVNOV INCCOM0.15%$846,35763.9K
46PAASPAN AMERN SILVER CORPCOM0.13%$717,70618.5K
47URNMSPROTT FDS TRURANIUM MINERS E0.12%$691,80311.4K
48SLBSCHLUMBERGER LTDCOM STK0.12%$676,98619.7K
49RXRXRECURSION PHARMACEUTICALS INCL A0.10%$580,720119.0K
50SDSANDRIDGE ENERGY INCCOM NEW0.10%$568,42250.4K
51AUTLAUTOLUS THERAPEUTICS PLCSPON ADS0.09%$503,404308.8K
52TSHATAYSHA GENE THERAPIES INCCOM SHS0.08%$441,123134.9K
53FATEFATE THERAPEUTICS INCCOM0.08%$419,856333.2K
54VALVALARIS LTDCL A0.07%$405,5238.3K
55NENOBLE CORP PLCORD SHS A0.07%$404,03614.3K
56RIGTRANSOCEAN LTDREGISTERED SHS0.06%$318,240102.0K
57SBSWSIBANYE STILLWATER LTDSPONSORED ADR0.05%$294,84826.2K
58TDWTIDEWATER INC NEWCOM0.05%$292,4085.5K
59VYGRVOYAGER THERAPEUTICS INCCOM0.04%$210,15045.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$480M60May 5, 202613F-HRchanges · EDGAR ↗
Q4 2025$543M57Feb 3, 202613F-HRchanges · EDGAR ↗
Q3 2025$556M59Nov 4, 202513F-HRchanges · EDGAR ↗
Q2 2025$464M55Jul 30, 202513F-HRchanges · EDGAR ↗
Q1 2025$384M56May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$442M64Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$402M82Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$392M129Aug 1, 202413F-HRchanges · EDGAR ↗
Q1 2024$374M117Apr 30, 202413F-HRchanges · EDGAR ↗
Q4 2023$359M114Feb 26, 2024RESTATEMENTchanges · EDGAR ↗
Q3 2023$336M115Nov 6, 202313F-HRchanges · EDGAR ↗
Q2 2023$347M124Jul 26, 2023RESTATEMENTchanges · EDGAR ↗
Q1 2023$298M126May 3, 202313F-HRchanges · EDGAR ↗
Q4 2022$264M150Feb 3, 202313F-HRchanges · EDGAR ↗
Q3 2022$275M226Nov 3, 202213F-HRchanges · EDGAR ↗
Q2 2022$302M252Jul 28, 202213F-HRchanges · EDGAR ↗
Q1 2022$452M279May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$504M253Feb 9, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.